<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Principal differential characteristics of inherited unconjugated hyperbilirubinemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Principal differential characteristics of inherited unconjugated hyperbilirubinemia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Principal differential characteristics of inherited unconjugated hyperbilirubinemia</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Crigler-Najjar syndrome type I</td> <td class="subtitle1">Crigler-Najjar syndrome type II</td> <td class="subtitle1">Gilbert syndrome</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Epidemiology and natural history</td> </tr> <tr> <td class="indent1">Mode of inheritance</td> <td>Autosomal recessive</td> <td>Autosomal recessive</td> <td>Autosomal recessive</td> </tr> <tr> <td class="indent1">Prevalence</td> <td>Rare</td> <td>Rare</td> <td>Common (approximately 9% of White people are homozygous for a variant TATAA box; 4 to 5% have hyperbilirubinemia)</td> </tr> <tr> <td class="indent1">Prognosis</td> <td>Kernicterus, unless vigorously treated</td> <td>Usually benign, kernicterus occurs rarely</td> <td>Benign</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Routine clinical evaluation</td> </tr> <tr> <td class="indent1">Serum bilirubin concentration*</td> <td>20 to 50 mg/dL<br/> (340 to 850 micromol/L)</td> <td>Usually 8 to 20 mg/dL<br/> (136 to 340 micromol/L)</td> <td>Usually &lt;3 mg/dL<br/> (&lt;51 micromol/L)</td> </tr> <tr> <td class="indent1">Routine liver function tests</td> <td>Normal</td> <td>Normal</td> <td>Normal</td> </tr> <tr> <td class="indent1">Effect of phenobarbital on serum bilirubin</td> <td>None</td> <td>Reduction</td> <td>Reduction</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Tests not routinely performed</td> </tr> <tr> <td class="indent1">Bilirubin glucuronides<sup>¶</sup></td> <td>Usually pale; contains small amounts of unconjugated bilirubin</td> <td>Bilirubin glucuronides present: Increased proportion of bilirubin monoglucuronide</td> <td>Bilirubin glucuronides present: Increased proportion of bilirubin monoglucuronide</td> </tr> <tr> <td class="indent1">Liver histology</td> <td>Normal, but fibrosis is present in approximately 40% of cases<sup>[1]</sup></td> <td>Normal</td> <td>Normal</td> </tr> <tr> <td class="indent1">Hepatic bilirubin UGT activity</td> <td>Absent</td> <td>Markedly reduced (10% of normal)</td> <td>Reduced (30% of normal)</td> </tr> <tr> <td class="indent1">45-minute plasma BSP retention<sup>Δ</sup></td> <td>Normal</td> <td>Normal</td> <td>Usually normal; may be prolonged</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>UGT: uridine diphosphate glucuronosyltransferase; BSP: bromosulfophthalein.</p>
<p>* Serum bilirubin concentrations depend on age and optimal medical management. In each of these disorders, further acute elevations may occur, triggered by fasting or intercurrent illnesses. The risk of severe acute exacerbations (eg, bilirubin &gt;20 mg/dL) and resulting kernicterus is high for Crigler-Najjar syndrome type I, low for Crigler-Najjar syndrome type II, and absent for Gilbert syndrome.</p>
<p>¶ Bilirubin glucuronides are measured by high-pressure liquid chromatography of bile collected from the duodenum.</p>
Δ Plasma BSP retention is prolonged in Dubin-Johnson and Rotor syndromes and in hepatobiliary cholestatic disorders.</div><div class="graphic_reference">Reference:
<ol>
<li>Mitchell E, Ranganathan S, McKiernan P, et al. Hepatic Parenchymal Injury in Crigler-Najjar Type I. J Pediatr Gastroenterol Nutr 2018; 66:588.</li>
</ol></div><div id="graphicVersion">Graphic 80818 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
